跳至主要内容
临床试验/CTRI/2025/03/082368
CTRI/2025/03/082368尚未招募3 期

A Randomised Controlled Trial To Evaluate The Efficacy Of Pradarari Churna And Pushyanuga Churna In The Management Of Asrigdara(Dysfunctional Uterine Bleeding)

Dr Pankaja1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月22日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To evaluate the effect of Pradarari churna and Pushyanuga churna in Asrugdara

研究概览

简要总结

This study is a randomized, parallel group trail comparing the efficacy of Pradarari churna(500mg BID) and Pushyanuga churna(3gm BID) from 3rd day of mensus to throughout the cycle for 2 months in total 40 patients with Asrugdara (Dysfunctional uterine bleeding) that will be conducted in India. The primary outcome measures will be to evaluate the effect of Pradarari churna and Pushyanuga churna. The secondary outcome measures will be to compare the efficacy of Pradarari churna and Pushyanuga churna in the management of Asrugdara.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
16.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • patient heaving heavy menstrual bleeding with change of 7-8 fully soaked pads/day prolonged bleeding for more than 7 days Intermenstrual bleeding within 21 days Hemoglobin more than 8gm/dl Both married and unmarried women.

排除标准

  • Patient diagnosed with genetic bleeding disorder and other systemic coagulative disorders Medical conditions as Acute PID, Liver disease, Chronic renal disease, HIV, TB, Diabetes mellitus, hypertension and Thyroid disorder Fibroid uterus, Uterine polyps, Adenomyosis, Tumors Pelvic endometriosis Medication as OCP, Warfarin, Enoxaparin, Apixaban and other anticoagulant drugs Patient with IUCD, Chronic illness and Postmenopausal bleeding.

结局指标

主要结局

To evaluate the effect of Pradarari churna and Pushyanuga churna in Asrugdara

时间窗: 4 months

次要结局

  • To compare the efficacy of Pradarari churna and Pushyanuga churna in the management of Arugdara(Dysfunctional uterine bleeding)(4 months)

研究者

发起方
Dr Pankaja
申办方类型
Other [Self(PG Scholar)]

研究点 (1)

Loading locations...

相似试验